Chemical Structure : BLZ945
CAS No.: 953769-46-5
Catalog No.: PC-43194Not For Human Use, Lab Use Only.
Sotuletinib (BLZ945) is a potent, selective, brain-penetrant CSF-1R inhibitor with biochemical IC50 of 1 nM, displays >3,200-fold selectivity over other kinases (c-Kit, PDGFR-β, Flt3, Abl, etc.).
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $98 | In stock | |
25 mg | $158 | In stock | |
50 mg | $248 | In stock | |
100 mg | $398 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Sotuletinib (BLZ945) is a potent, selective, brain-penetrant CSF-1R inhibitor with biochemical IC50 of 1 nM, displays >3,200-fold selectivity over other kinases (c-Kit, PDGFR-β, Flt3, Abl, etc.).
Sotuletinib (BLZ945) inhibits CSF-1-dependent proliferation in bone marrow-derived macrophages (BMDMs) with EC50 of 67 nM, and decreases CSF-1R phosphorylation.
Sotuletinib (BLZ945) blocks glioma progression and significantly improves survival, efficiently limits tumor progression combining with PD-1/PD-L1 blocking antibodies in neuroblastoma.
M.Wt | 398.4787 | |
Formula | C20H22N4O3S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 30 mg/mL |
|
Chemical Name/SMILES |
2-Pyridinecarboxamide, 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl- |
1. Pyonteck SM, et al. Nat Med. 2013 Oct;19(10):1264-72.
2. Pass HI, et al. Oncotarget. 2016 Aug 30;7(35):56408-56421.
3. Mao Y, et al. Clin Cancer Res. 2016 Aug 1;22(15):3849-59.
4. Quail DF, et al. Science. 2016 May 20;352(6288):aad3018.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright